The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer

N Engl J Med. 2016 Feb 4;374(5):454-68. doi: 10.1056/NEJMra1503523.
No abstract available

Publication types

  • Review

MeSH terms

  • Age Factors
  • Breast Neoplasms / genetics
  • Breast Neoplasms / prevention & control*
  • Decision Making
  • Early Detection of Cancer
  • Female
  • Genes, BRCA1
  • Genes, BRCA2
  • Heterozygote
  • Humans
  • Mastectomy*
  • Mutation
  • Ovarian Neoplasms / genetics
  • Ovarian Neoplasms / prevention & control*
  • Ovariectomy*
  • Risk
  • Selective Estrogen Receptor Modulators / therapeutic use
  • Tamoxifen / therapeutic use

Substances

  • Selective Estrogen Receptor Modulators
  • Tamoxifen